FDA Approved: RIFAMPIN — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Rifampin filed by Chartwell RX, LLC, leading to changes in the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leprosy
• Meningococcal Disease
• Tuberculosis

Drugs mentioned

• RIFAMPIN (RIFAMPIN)

Snippet

SUPPL AP for RIFAMPIN (RIFAMPIN)